Clients

Companies that have recently invested in an URCH report include:

3M Drug Delivery Systems
AAI Japan
Abbott Laboratories
Aliachem a.s.
Alk Abello A/S
Alkermes Inc.
Alliance Pharmaceuticals
Alpha Corporate
ALTANA Pharma
Altana Pharma AG
Amersham Health
Amgen Belgium NV
Amylin Europe Ltd
Analysis Group, Inc.
Andrx Corporation
Antares Pharma AG
Applied Biosystems
Arthur D Little
Aspen Technology
Aspreva Pharmaceuticals
AstraZeneca
Axis-Shield ASA
Bachem Americas
Bain & Company (Germany)
BalkanPharma
Bank of America
BASF Aktiengesellschaft
Bayer Plc
Bear Stearns
Belupo d.d.
Bespak Europe Ltd
BIA Separations
Biotie Therapies Corp
Boehringer Ingelheim GmbH
Booz Allen & Hamilton AG
Bovis Lend Lease Pharmaceutical
Bristol-Myers Squibb Co
British Sugar Plc
BT plc
BTC Sahinpasic
Cambridge Pharma Consultancy
Candesic
Cardinal Health
Catalina Marketing Corporation
CDH Consilio GmbH
Celadon Laboratories
Cephalon Inc
Chesyl Pharma Ltd
Chugai Pharma Europe Ltd
Concordis Ltd
Controlled Therapeutics (Scotland) Ltd
Corning SAS
Crompton Corporation
Daiichi Medical Research
DAVA Pharmaceuticals
Deloitte
Delta Biotechnology Ltd
Dickstein Shapiro Morin & Oshinsky
Domanski Zakrzewski Palinka s.p.k
Dow Chemical
Doyle Isobel
Dynogen Pharmaceuticals
EBE / EFPIA
Eisai Europe Ltd
Eli Lilly & Company
Endo Pharmaceuticals
Erasmus University Rotterdam
Ernst & Young AG
Euro RSCG Life
European Generics Association
E-Z-EM Inc
Fabrel Lotos
Fischer Scientific
FlowServe Ahaus GmbH
Fluor Corporation
Forest Laboratories
Frankel Group
Gel Med Sciences Ctr.
Genentech Inc.
GeneSegues Inc.
Genethon
Genzyme Europe B.V
GlaxoSmithKline
Greenhill & Co International LLP
H Lundbeck A/S
Hanmi Pharmaceuticals Co Ltd
Hikma Pharmaceuticals
Hoffman La Roche
Holger Decker
Honeywell Speciality Films Healthcare
Hong Kong Trade Development Council
HORN Pharmaceutical Consulting
HSBC Investment Bank
Hungarian Pharmaceutical Manufacturers Association
IMS Health
INFARMED
INO Therapeutics LLC
Intercell Biomedical Ltd
ISP Global Technologies Deutschland
IUT
Janssen Pharmaceutica
Jexys Pharmaceuticals
JSC AG
Karl Bartolo
Karyon
KPMG
Kyorin Europe GmbH
Laboratorios Almirall
Labormed Pharma S.A
L.E.K Consulting
LEO Pharma A/S
LG Life Sciences
Liplasome
Lloyds Pharmacy
Lundbeck (France)
Martinedale Pharmaceuticals
McKinsey & Co
MED-EL GmbH
Medipolis GMP Ltd
Merck & Co
Modular BVBA
Molnlycke Health Care Ltd
MPA Pharma
Myris Trade Ltd
Nalco Ltd
Nizhpharm JSC
Norgine Ltd
Novartis AG
Novo Nordisk A/S
NPS Pharmaceuticals Inc,
Nycomed Group
Oracle GB
Organon NV
Ortho-McNeil Neurologics, Inc.
Otsuka America Pharmaceutical, Inc.
Ovation Pharmaceuticals, Inc.
Oxera
Oxford Lasers Ltd
Perlos Corporation
Pfaudler Balfour
Pfizer Inc
Pharmaxis UK Ltd
Philips International BV
Pierce Biotechnology Inc.
Plant Bioscience Ltd
Pliva
Procter & Gamble Technical Centres
PT.Sanbe Farma
Purdue Pharma
Quintiles
Ranbaxy Inc.
Replicor Inc
Roland Berger Strategy Consultants
SACHEM
Safa Galenica
Sanofi-Synthelabo SA NV
Sanofi-Synthlebo Groupe
Savient Pharmaceuticals
Schering-Plough
Schwarz Pharma Ltd
Scottish Development International
Serono Internation SA
Shire Pharmaceuticals
Simon-Kicher & Partners
SK Energy & Chemical Inc.
SLOVART G.T.G. s.r.o
Smith & Nephew plc
Solvay Pharmaceuticals BV
SPRI Corp
Steingrimur Wernersson
Strassner GmbH
Super-Pharm Poland Sp. z.o.o.
Swedish Orphan International AB
SynerLAB SA
Takeda
Tamin Pharmaceutical Co.
The Boston Consulting Group
TikoMed AB
UAM Iztapalapa
UCB (Belgium)
Uriach Group
Valeo Management L.P
VBZ d.o.o.
VIATRIS Pharmaceuticals S.A.U.
Watson Pharmaceuticals
Welland Medical Ltd
Wyeth Pharmaceuticals
Yamanouchi Europe B.V.
Z. F. Polpharma SA

If you do have any questions please contact us and we will be pleased to assist.